DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

What is the Resonance Specialities Ltd (RESONANCE) share price today?

Resonance Specialities Ltd (RESONANCE) is trading at ₹136.25 on the BSE, up 0.00% on the day. Source: DocStoX.

What is the PE ratio of Resonance Specialities Ltd?

Resonance Specialities Ltd has a price-to-earnings (PE) ratio of 23.9 in the Commodities sector.

What is the market capitalisation of Resonance Specialities Ltd?

Resonance Specialities Ltd has a market capitalisation of approximately ₹153 crore.

Resonance Specialities Ltd

RESONANCE·BSE·Commodities

₹136.25▲ +0.00 (+0.00%)

Commodities · Chemicals & Petrochemicals

A steady, established business

Day₹132.65

₹136.70

52W₹77

₹14883%

Open

₹136.20

High

₹136.70

Low

₹132.65

Prev Close

₹136.25

Volume

3.5K

VWAP

₹134.79

Snapshot

Key fundamentals

Market Cap

₹153 Cr

P/E Ratio

23.95Fair

P/B Ratio

2.26

EPS

₹5.69

Book Value

₹60.28

ROE

14.19%Average

ROCE

15.00%Decent

Dividend Yield

0.73%

Debt / Equity

0.03Low

Face Value

₹10.00

52W High

₹148.00

52W Low

₹77.00

Sector

Commodities

Industry

Chemicals & Petrochemicals

Avoid

None moatHigh uncertainty

Fair value estimate

₹62

▼ 54.7%downside

Trading at ₹136 — 55% above our estimate

BearFair valueBull

₹52₹62₹71

/100

Business quality — Solid

Growth 50Profitability 42Efficiency 35Valuation 82

Plain English

Our view

A steady, established business
Virtually debt-free balance sheet

Strengths

Virtually debt-free balance sheet
Promoters hold a controlling stake

How we got there

Fair value methods

Residual income

14% ROE fading to 13% over ~3 yrs, on ₹60 book

₹62

Relative P/E

Needs ≥3 peers with P/E

—

Graham floor

Conservative floor: √(22.5 × EPS × book value/share)

₹61

Analyst target

No analyst coverage

—

Blended fair value₹62

What the numbers say

Investment thesis

Bull case

Virtually debt-free balance sheet
Promoters hold a controlling stake

Bear case

No notable red flags from the current metrics.

Free — see our deterministic Fair Value range, business quality score, and the full bull/bear case for this stock.

Snapshot

Key statistics

P/E

23.9Fair

Below 15× is value territory; above 35× prices in strong growth

ROE

14.2%Average

Above 15% is considered healthy for Indian equities

ROCE

15.0%Decent

Above 18% means capital is working hard

Debt/Eq

0.03Low

Below 0.5 is comfortable; above 1.5 strains the balance sheet

Mkt Cap

₹153 Cr

P/B

2.26

EPS

₹5.69

Div Yield

0.73%

What changed

Recent changes

Domestic institutions+1.5% stake last quarter

What matters

News impact

Overview

Valuation

Reasonable

P/E 23.9×

Growth

Strong

+17% rev CAGR

Profitability

Healthy

14.2% ROE

Financial health

Rock solid

D/E 0.03

Momentum

N/A

No technicals

Today

Trading activity

Delivery %—

Turnover₹4.77L Cr

Trades33

VWAP₹134.79

Face value₹10.00

Market depth

Market depth available during market hours

Snapshot

Technical signals

Compounded annual growth

Growth (CAGR)

Revenue

+16.6%

+5.6%

10Y

+8.9%

Profit

+27.6%

-1.1%

10Y

+26.4%

EPS

-14.5%

-21.5%

10Y

+10.2%

Profile

Pros

Company has reduced debt.
Company is almost debt free.
Debtor days have improved from 83.3 to 56.2 days.

Watch-outs

Cons

Company has a low return on equity of 10.9% over last 3 years.

Forecast

News

Peers

Financials

Growth

Shareholding

Ownership

Ownership breakdown

Quarter ending 30 Jun 2026

Domestic institutions added 1.52 pts last quarter. The QoQ column shows each group's change versus the prior quarter.

54%

Promoter

Promoters

54.3%0.00

Public

34.2%-1.10

FII / FPI

0.0%0.00

DII

1.6%+1.52

Others

10.0%

Total shareholders

10,998-274 QoQ

Quarterly trend

Ownership over time

Q1 FY27

Promoter54.25%

FII0.03%

DII1.55%

Public34.19%

Others9.98%

Corporate Actions

Bulk & Block Deals

Filings

MF Holdings

Technicals

FAQs

Quick reference

Frequently asked questions

Incorporated in 1989, Resonance Specialties Ltd manufactures Pyridine, Picoline, Cynopyridine and derivatives of the same[1]